{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:20:03Z","timestamp":1788373203737,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41379-022-01062-2","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T07:05:57Z","timestamp":1648019157000},"page":"1287-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["p53 null phenotype is a \u201cpositive result\u201d in urothelial carcinoma in situ"],"prefix":"10.1016","volume":"35","author":[{"given":"Ankur R.","family":"Sangoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-4004","authenticated-orcid":false,"given":"Emily","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-9284","authenticated-orcid":false,"given":"Eman","family":"Abdulfatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-8846","authenticated-orcid":false,"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-8564","authenticated-orcid":false,"given":"Michelle","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Falzarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-5404","authenticated-orcid":false,"given":"Aaron M.","family":"Udager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Priya","family":"Kunju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01062-2_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1038\/s41379-022-01062-2_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0140-6736(90)90801-B","article-title":"Increased expression of mutant forms of p53 oncogene in primary lung cancer","volume":"335","author":"Iggo","year":"1990","journal-title":"Lancet"},{"key":"10.1038\/s41379-022-01062-2_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00019606-199303000-00006","article-title":"Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives","volume":"2","author":"Lohmann","year":"1993","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.2024123","article-title":"Identification of p53 gene mutations in bladder cancers and urine samples","volume":"252","author":"Sidransky","year":"1991","journal-title":"Science"},{"key":"10.1038\/s41379-022-01062-2_bib5","first-page":"1389","article-title":"p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer","volume":"143","author":"Esrig","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.bjc.6601748","article-title":"A population-based study of immunohistochemical detection of p53 alteration in bladder cancer","volume":"90","author":"Kelsey","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1038\/s41379-022-01062-2_bib7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/0959-8049(95)00443-2","article-title":"p53 overexpression as a prognostic factor for advanced stage bladder cancer","volume":"31A","author":"Kuczyk","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1038\/s41379-022-01062-2_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1995.41","article-title":"p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder","volume":"71","author":"Serth","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1038\/s41379-022-01062-2_bib9","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib10","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2559.2011.03907.x","article-title":"Patterns of p53 immunoreactivity in endometrial carcinomas: \u2018all or nothing' staining is of importance","volume":"59","author":"McCluggage","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/s41379-022-01062-2_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/his.13225","article-title":"p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant","volume":"71","author":"Hodgson","year":"2017","journal-title":"Histopathology"},{"key":"10.1038\/s41379-022-01062-2_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-020-00984-2","article-title":"CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia","volume":"15","author":"Neal","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2020.02.008","article-title":"Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap","volume":"98","author":"Nguyen","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2020.07.006","article-title":"Invasive plasmacytoid urothelial carcinoma: a comparative study of E-cadherin and P120 catenin","volume":"102","author":"Sangoi","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000478-200103000-00010","article-title":"Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion","volume":"25","author":"McKenney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib17","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41379-020-0543-y","article-title":"Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer","volume":"33","author":"Chan","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with Equivocal Atypia","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1038\/s41379-022-01062-2_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/PAS.0000000000000114","article-title":"Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20\/CD44s\/p53) and \u03b1-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia","volume":"37","author":"Aron","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000401","article-title":"Flat Urothelial Lesions with Atypia: interobserver concordance and added value of immunohistochemical profiling","volume":"26","author":"Lawless","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1038\/s41379-022-01062-2_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.MP.0000056628.38714.5D","article-title":"Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia","volume":"16","author":"Mallofr\u00e9","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.humpath.2012.08.011","article-title":"Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases","volume":"44","author":"Oliva","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2019.04.018","article-title":"Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical","volume":"90","author":"Pederzoli","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00129039-200212000-00007","article-title":"p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder","volume":"10","author":"Sun","year":"2002","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1038\/s41379-022-01062-2_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1746-1596-4-35","article-title":"Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies","volume":"4","author":"Yildiz","year":"2009","journal-title":"Diagn. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"K\u00f6bel","year":"2010","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib28","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res."},{"key":"10.1038\/s41379-022-01062-2_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(17)32745-3","article-title":"Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder","volume":"152","author":"Sarkis","year":"1994","journal-title":"J. Urol."},{"key":"10.1038\/s41379-022-01062-2_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00184241","article-title":"P53 accumulation in precursor lesions and early stages of bladder cancer","volume":"12","author":"Schmitz-Dr\u00e4ger","year":"1994","journal-title":"World J. Urol."},{"key":"10.1038\/s41379-022-01062-2_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAP.0000000000000239","article-title":"Urothelial Carcinoma In Situ (CIS): new insights","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0000000000000308","article-title":"The Genitourinary Pathology Society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of Neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv. Anat. Pathol."},{"key":"10.1038\/s41379-022-01062-2_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 mutational spectrum in Endometrioid and Serous Endometrial Cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int J. Gynecol Pathol."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01062-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200285X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200285X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:29:18Z","timestamp":1760228958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522200285X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S089339522200285X"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01062-2","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p53 null phenotype is a \u201cpositive result\u201d in urothelial carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01062-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}